Cargando…
The nicotine-degrading enzyme NicA2 reduces nicotine levels in blood, nicotine distribution to brain, and nicotine discrimination and reinforcement in rats
BACKGROUND: The bacterial nicotine-degrading enzyme NicA2 isolated from P. putida was studied to assess its potential use in the treatment of tobacco dependence. RESULTS: Rats were pretreated with varying i.v. doses of NicA2, followed by i.v. administration of nicotine at 0.03 mg/kg. NicA2 had a rap...
Autores principales: | Pentel, Paul R., Raleigh, Michael D., LeSage, Mark G., Thisted, Thomas, Horrigan, Stephen, Biesova, Zuzana, Kalnik, Matthew W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056991/ https://www.ncbi.nlm.nih.gov/pubmed/30041697 http://dx.doi.org/10.1186/s12896-018-0457-7 |
Ejemplares similares
-
Attenuating nicotine’s effects with high affinity human anti-nicotine monoclonal antibodies
por: Raleigh, Michael D., et al.
Publicado: (2021) -
Optimization of a nicotine degrading enzyme for potential use in treatment of nicotine addiction
por: Thisted, Thomas, et al.
Publicado: (2019) -
Complete Genome Sequence of Sphingomonas sp. Strain NIC1, an Efficient Nicotine-Degrading Bacterium
por: Zhu, Xiongyu, et al.
Publicado: (2016) -
NIC1 cloning and gene editing generates low‐nicotine tobacco plants
por: Qin, Qiulin, et al.
Publicado: (2021) -
Nicotinism
Publicado: (1877)